Concepedia

Granulomonocytic progenitors are key target cells of azacytidine in higher risk myelodysplastic syndromes and acute myeloid leukemia

Ashfaq Ali, Justine Penneroux, Reinaldo Dal Bello, Aline Massé, Samuel Quentin, Ashwin Unnikrishnan, Lucie Hernandez, Emmanuel Raffoux, Raouf Ben Abdelali, Aline Renneville,

Leukemia · 2018 · 10 citations · 9 references

DOI

Concepts

References

9

<i>TP53</i> and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes

John S. Welch, Allegra A. Petti, Christopher A. Miller et al. · New England Journal of Medicine · 2016 · 784 citations · Full text

, , +17

Coexistence of LMPP-like and GMP-like Leukemia Stem Cells in Acute Myeloid Leukemia

Nicolas Goardon, Emanuele Marchi, Ann Atzberger et al. · Cancer Cell · 2011 · 640 citations · Full text

, , +14

Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM)

Sylvain Thépot, Raphaël Itzykson, Valérie Seegers et al. · Blood · 2010 · 156 citations

, , +17

Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia

Charles Craddock, Lynn Quek, Nicolas Goardon et al. · Leukemia · 2012 · 140 citations

, , +13

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Ashwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck et al. · Cell Reports · 2017 · 130 citations · Full text

, , +16